Ads
related to: pnh blood disorder- Ongoing Hemolysis In PNH
Many Patients Continue To
Experience Signs & Symptoms Of PNH
- Challenges Of PNH
Challenges Remain For Many Treated
Patients With PNH
- Tools & Resources
Get Tools, Resources, and Support
For You & Your Patients
- Efficacy Study
Read The Clinical Data And Efficacy
Of a PNH Treatment Option
- Important Safety Info
Get The Full Important Safety
Information for a PNH Treatment
- Safety Profile
Read About The Adverse Reactions
to a PNH Treatment
- Ongoing Hemolysis In PNH
Search results
Novartis gets FDA approval of closely watched rare disease drug
BioPharma Dive via Yahoo Finance· 4 months agoDive Brief: The Food and Drug Administration has approved a new Novartis drug for adults with a rare...
Novartis (NVS) Gets FDA Nod for Rare Blood Disorder Drug
Zacks via Yahoo Finance· 4 months agoNovartis NVS announced that the FDA approved iptacopan as the first oral monotherapy for the...
Rare Blood Disorder Treatment Breakthrough: Novartis' Candidate Improves Hemoglobin To Near-Normal...
Benzinga via Yahoo Finance· 12 months agoNovartis AG (NYSE: NVS) released detailed results from the Phase 3 APPOINT-PNH trial of...
Could This Be Novartis' Next Blockbuster Medicine?
Motley Fool· 1 year agoLast month, Novartis (NYSE: NVS) revealed encouraging results from a phase 3 clinical trial of the rare-disease drug candidate known as iptacopan for...
Novartis' Rare Blood Disorder Therapy Aces Second Late-Stage Trial
Benzinga via Yahoo Finance· 1 year agoNovartis AG's (NYSE: NVS) Phase 3 APPOINT-PNH study of iptacopan in complement-inhibitor-naïve...
Novartis Experimental Drug Shows Meaningful Superiority Over Previous Treatment In Rare Blood...
Benzinga via Yahoo Finance· 1 year agoNovartis AG's (NYSE: NVS) investigational oral monotherapy iptacopan was superior to anti-C5...
Pharma Stock Roundup: ABBV to Buy CERE, JNJ's 2024 View, LLY & NVS Get FDA Nod
Zacks via Yahoo Finance· 4 months agoThis week, AbbVie ABBV announced a definitive agreement to acquire neuroscience drugmaker Cerevel...
Novartis Shares Detailed Results From Experimental Drug For Rare Blood Disorder
Benzinga via Yahoo Finance· 1 year agoNovartis AG (NYSE: NVS) announced detailed results from the pivotal Phase 3 APPLY-PNH trial. The...
AstraZeneca's Blood Clot Treatment Hits Primary Goal In Rare Blood Disorder Trial
Benzinga via Yahoo Finance· 2 years agoAstraZeneca Plc (NASDAQ: AZN) said its Danicopan add-on anti-blood-clotting drug met a primary...
AstraZeneca's Add On Treatment With Standard Care Improves Hemoglobin Levels In Rare Blood Disorder
Benzinga via Yahoo Finance· 10 months agoAstraZeneca Plc (NASDAQ: AZN) released data from the Phase 3 ALPHA trial of danicopan as an add-on...
Ads
related to: pnh blood disorder
